BOUNDLESS BIO, INC. Other Noncash Income (Expense)
BOUNDLESS BIO, INC. (BOLD) reported Other Noncash Income (Expense) of -$102.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-03-09
- BOUNDLESS BIO, INC. other noncash income (expense) for the quarter ending 2023-12-31 was $0.00.
- BOUNDLESS BIO, INC. other noncash income (expense) for the quarter ending 2023-09-30 was $0.00.
- BOUNDLESS BIO, INC. other noncash income (expense) for the quarter ending 2023-06-30 was $0.00.
- BOUNDLESS BIO, INC. other noncash income (expense) for the quarter ending 2023-03-31 was -$25.00K.
- BOUNDLESS BIO, INC. other noncash income (expense) for fiscal 2024 was -$102.00K.
- BOUNDLESS BIO, INC. other noncash income (expense) for fiscal 2023 was -$25.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$102.00K 10-K · filed 2026-03-09 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 derived: sum of 3 quarters · filed 2025-03-27 | -$25.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | -$25.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$25.00K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$25.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |